Modelling the Cost-Effectiveness of Cervical Cancer Screening with Hpv Self-Sampling and Molecular Triage for Women Aged 60-69 Years
SSRN, ISSN: 1556-5068
2024
- 104Usage
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Objective The aim of this cost-effectiveness analysis is to, from a health economics perspective, compare the current Swedish national cervical screening program for women aged 60-69 years with self-sampling and molecular triage strategies.Methods Based on data from a Swedish population-based cervical screening study, current screening is compared with modelled molecular triage strategies in a cost-effectiveness analysis. The comparison is made with respect to healthcare resource use measured as total costs and health effects, measured as number of identified high-grade squamous intraepithelial lesions (HSIL).Results Screening with molecular triage either leads to decreases in effect or significant cost increases due to higher rate of HPV-positive screening samples and higher number of colposcopies.Conclusions Molecular triage, whether screening is based on self-sampling or professional sampling, does not appear to be cost-effective in this age group compared to the currently implemented strategy with cytological triage.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know